The combination of radiotherapy and immunotherapy using glycated chitosan as an immunological stimulant

Chun-Yuan Chang; Jyh-Der Leu M.D.; Chung-Yi Wang M.D.; Wei  R. Chen; Yi-Jang Lee

doi:10.1117/12.2080950

9 March 2015 The combination of radiotherapy and immunotherapy using glycated chitosan as an immunological stimulant

Chun-Yuan Chang, Jyh-Der Leu M.D., Chung-Yi Wang M.D., Wei R. Chen, Yi-Jang Lee

Proceedings Volume 9324, Biophotonics and Immune Responses X; 932416 (2015) https://doi.org/10.1117/12.2080950
Event: SPIE BiOS, 2015, San Francisco, California, United States

Abstract

Immunotherapy has been reported to effectively treat various cancers. In addition, scientists are dedicated in finding whether the combination of radiotherapy and immunotherapy can efficiently suppress cancer progression and recurrence. Although radiotherapy has been widely used for breast cancer, better strategies to overcome the latestage breast cancer remains explored. The glycated chitosan (GC), a novel immunological stimulant, was demonstrated to trigger local immune response facilitating the enhancement of radiosensitivity. Our previous study also revealed that the cell mortality and invasive ability were decreased under GC treatment, but the underlying mechanism remains unclear. In this study, we used 4T1-3R-L, a derived murine breast cancer cell line from the spontaneous metastasized liver lesion. We combined ionizing radiation with GC to treat 4T1-3R-L and found the expression of DNA damage-related genes such as gamma-H2AX was more than radiation alone In addition, the cell cycle distribution and colony forming assay showed an increased sub-G1 population and decreased cell survival rate after IR combined GC treatment. Taken together, we sought to elucidate the underlying mechanism by the investigation of DNA damage repair process when IR combined with GC, and to explore another advantage of GC to aid other cancer treatments. Based on our most updated results, the GC treatment is able to effectively increase the radiosensitivity through an immune-responsive signaling transduction, indicating that GC could be a valuable therapeutic strategy for treating against advanced breast cancers.

Citation Download Citation

Chun-Yuan Chang, Jyh-Der Leu M.D., Chung-Yi Wang M.D., Wei R. Chen, and Yi-Jang Lee "The combination of radiotherapy and immunotherapy using glycated chitosan as an immunological stimulant", Proc. SPIE 9324, Biophotonics and Immune Responses X, 932416 (9 March 2015); https://doi.org/10.1117/12.2080950

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
5 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Breast cancer

Radiotherapy

Cancer

Infrared radiation

Ionizing radiation

Biomedical optics

Liver

Show All Keywords

Keywords/Phrases

Search In:

Publication Years